NuCana Q3 2024 Earnings SmallerthanExpected Loss as Biotech Advances Oncology Pipeline ASTC Q1 2024 Earnings Loss per Share of 179 Reflects Continued PreRevenue Investment Phase MKTW Q1 2026 Earnings Significant EPS Miss Despite Positive Market Reaction FBYD Q1 2026 Earnings Narrowing Losses Amid Strategic Transformation BWIN Q1 2026 Earnings EPS Misses Estimates Amid Operating Headwinds Telomir Pharmaceuticals Inc TELO Q4 2025 Earnings Wider Than Expected Loss Highlights PreRevenue Challenges FINV Q4 2025 Earnings Earnings Per Share Reported at 1722925 Amid Market Headwinds RES Q1 2026 Earnings EPS Beats Estimates by 1858 Amid Broader Market Headwinds RDHL Q2 2022 Earnings Significant EPS Miss Despite Stock Gain Community Bancorp CMTV Q4 2025 Earnings Solid EPS Performance Amid Steep Market Backlash ROP Q1 2026 Earnings EPS Surpasses Estimates with 258 Beat Stock Edges Higher MLEC Q2 2025 Earnings EPS Surprises to the Upside as PreRevenue Science Company Narrows Loss